Ultrasound-targeted antisense oligonucleotide attenuates ischemia/reperfusion-induced myocardial tumor necrosis factor-alpha.

[1]  C. Hartley,et al.  Clinical relevance of myocardial “stunning” , 1991, Cardiovascular Drugs and Therapy.

[2]  R V Shohet,et al.  Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. , 2000, Circulation.

[3]  J D Thomas,et al.  Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. , 2000, Journal of the American College of Cardiology.

[4]  A. Harken,et al.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. , 1999, Critical care medicine.

[5]  D. H. Mitchell,et al.  Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. , 1999, Circulation.

[6]  T C Skalak,et al.  Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. , 1998, Circulation.

[7]  T C Skalak,et al.  Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and Its Local Effects on Tissue. , 1998, Circulation.

[8]  D. Meldrum.  Tumor necrosis factor in the heart. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[10]  G. Freeman,et al.  Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischaemia , 1997, Clinical and experimental immunology.

[11]  S. Kaul,et al.  Interactions between microbubbles and ultrasound: in vitro and in vivo observations. , 1997, Journal of the American College of Cardiology.

[12]  M. Guenounou,et al.  Inhibition of human TNF alpha and LT in cell-free extracts and in cell culture by antisense oligonucleotides. , 1996, Biochimica et biophysica acta.

[13]  H. Sochor,et al.  Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. , 1996, European heart journal.

[14]  P. Iversen,et al.  Interaction of diagnostic ultrasound with synthetic oligonucleotide‐labeled perfluorocarbon‐exposed sonicated dextrose albumin microbubbles. , 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[15]  U. Deligonul,et al.  Detection of regional perfusion abnormalities during adenosine stress echocardiography with intravenous perfluorocarbon-exposed sonicated dextrose albumin. , 1996, American heart journal.

[16]  T. Porter,et al.  Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. , 1996, Journal of the American College of Cardiology.

[17]  G. Freeman,et al.  Tumor Necrosis Factor-α Induces a Biphasic Effect on Myocardial Contractility in Conscious Dogs , 1996 .

[18]  D. Altavilla,et al.  Tumour necrosis factor mediates E-selectin production and leukocyte accumulation in myocardial ischaemia-reperfusion injury. , 1995, Pharmacological research.

[19]  P. Iversen,et al.  Characterization of binding sites, extent of binding, and drug interactions of oligonucleotides with albumin. , 1995, Antisense research and development.

[20]  G. Fantuzzi,et al.  Cytokines in Acute Myocardial Infarction: Selective Increase in Circulating Tumor Necrosis Factor, Its Soluble Receptor, and Interleukin‐1 Receptor Antagonist , 1994, Journal of cardiovascular pharmacology.

[21]  M. Odeh.  Tumor necrosis factor-α as a myocardial depressant substance , 1993 .

[22]  T. Sakamoto,et al.  Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. , 1993, American heart journal.

[23]  Y. Başaran,et al.  Serum Tumor Necrosis Factor Levels in Acute Myocardial Infarction and Unstable Angina Pectoris , 1993, Angiology.

[24]  R. Bolli.  Myocardial 'stunning' in man. , 1992, Circulation.

[25]  F. Pagani,et al.  Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. , 1992, The Journal of clinical investigation.

[26]  U. Ikeda,et al.  Serum interleukin 6 levels become elevated in acute myocardial infarction. , 1992, Journal of molecular and cellular cardiology.

[27]  J. Kovacs,et al.  The cardiovascular response of normal humans to the administration of endotoxin. , 1989, The New England journal of medicine.

[28]  P. Libby,et al.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. , 1989, Journal of immunology.